FY2025 · ended Dec 31, 2025 · Revenue $7.23M, -9.5% YoY · Filed Mar 12, 2026
Syra Health Corp. (SYRA) files with the SEC under industry code 7361, Services-Employment Agencies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $7.2 million and a net loss of $896,333. Free cash flow was -$447,853. As of Sep 30, 2026 it held $2.4 million in cash and investments and $57,010 in total debt.
Revenue (TTM)
$8.96M
+19.5% vs year-ago TTM
Net income (TTM)
$701,261
+155.4% vs year-ago TTM
Operating cash flow (TTM)
$685,831
+283.7% vs year-ago TTM
Free cash flow
$-447,853
+84.8% vs prior year
EPS (TTM)
$0.05
+146.3% vs year-ago TTM
Dividend per share
None
Shares outstanding
11.34M
+0.2% vs prior year
Net cash
$2.33M
as of Sep 30, 2026
Operating margin
6.8%
FY 2026
Company profile
- Industry
- Services-Employment Agencies (SIC 7361)
- Listed as
- SYRA (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Carmel, IN
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1922335
Other Services-Employment Agencies companies
- Korn Ferry KFY
- GEE Group Inc. JOB
- Baiya International Group Inc. BIYA
- Click Holdings Ltd. CLIK
- CALM Chain International Ltd CCIL
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
|---|---|---|---|
| Revenue | $7.2M | $8.0M | $5.5M |
| Operating income | -$904,324 | -$3.8M | -$2.9M |
| Net income | -$896,333 | -$3.8M | -$2.9M |
| Diluted EPS | -$0.08 | -$0.50 | -$0.60 |
| Operating cash flow | -$447,746 | -$2.9M | -$2.8M |
| Free cash flow | -$447,853 | -$2.9M | -$2.8M |
| Total assets | $2.8M | $3.7M | $4.9M |
| Total liabilities | $674,739 | $800,761 | $910,072 |
| Stockholders' equity | $2.1M | $2.9M | $4.0M |
| Cash and investments | $1.6M | $2.4M | $3.3M |
| Total debt | $27,401 | $299,190 | $63,199 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 23, 2026 | Jul 23, 2026 |
| ARS | Annual report to shareholders | Jun 1, 2026 | Dec 31, 2025 |
All 160 Syra Health Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.